Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer

Fumitoshi Hirokawa,Mitsuhiro Asakuma,Koji Komeda,Tetsunosuke Shimizu,Yoshihiro Inoue,Syuji Kagota,Atsushi Tomioka,Kazuhisa Uchiyama

Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer

2019

Fumitoshi Hirokawa
Mitsuhiro Asakuma
Koji Komeda
Tetsunosuke Shimizu
Yoshihiro Inoue
Syuji Kagota
Atsushi Tomioka
Kazuhisa Uchiyama

Purpose Neoadjuvant chemotherapy (NAC) for resectable liver metastasis from colorectal cancer (CRLM) is used widely, but its efficacy lacks clear evidence. This study aimed to clarify its worth and develop appropriate treatment strategies for CRLM.

Keywords:

General surgery
Colorectal cancer
Metastasis
Chemotherapy
Medicine
Gastroenterology
initial treatment
Surgical oncology
Perioperative
Surgery
Internal medicine
surgical failure
Hepatectomy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations